Dialysis News and Research

Latest Dialysis News and Research

Simple laboratory test predicts risk of kidney injury after surgery

A simple laboratory test may provide a new way for doctors to identify patients at risk of developing potentially severe acute kidney injury (AKI) after surgery up to three days before the problem would otherwise be detected, reports a pilot study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology .

14 Mar 2008

Discovery could lead to much-needed kidney failure treatment

The unwanted activation of an important cell-signaling pathway may play a role in two kidney problems that are major causes of end-stage renal disease, scientists at the Albert Einstein College of Medicine of Yeshiva University have found.

13 Mar 2008

Simple laboratory test predicts risk of kidney injury after surgery

13 Mar 2008

Study identifies reasons patients referred late to nephrologists

Some patients with kidney disease aren't referred to kidney specialists in time to delay disease progression and improve their prognosis for a variety of reasons, according to researchers at Wake Forest University School of Medicine and colleagues.

1 Mar 2008

Hormones produced by the heart eliminate pancreatic cancer in mice

Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).

27 Feb 2008

New Alzheimer's patent by Affiris

Affiris GmbH has secured another Europe-wide patent for an innovative method of treating Alzheimer's disease. This new blood-cleansing method is similar to dialysis and is designed to reduce the amount of harmful protein deposits in the brain. It is based on the AFFITOME technology established by Affiris, which was patented in October 2007 for an Alzheimer's vaccine.

27 Feb 2008

Kidney donor age linked to aortic siffening

Transplantation of kidneys from older donors is followed by increased stiffening of the recipient's aorta - which may help to explain the higher rates of cardiovascular disease and death in patients receiving kidneys from "expanded criteria" donors, reports a study in the April Journal of the American Society of Nephrology.

22 Feb 2008

Test for blood sugar not accurate in diabetic dialysis patients

The standard test for measuring blood sugar control in people with diabetes is not accurate in those on kidney hemodialysis, according to new research at Wake Forest University Baptist Medical Center.

21 Feb 2008

Study confirms aprotinin drug increases cardiac surgery death rate

The largest study to date of a controversial cardiac surgery drug shows it increases death rates and damages kidney function, according Duke University Medical Center researchers.

21 Feb 2008

Standard test for blood sugar control not accurate in diabetic dialysis patients

21 Feb 2008

Doctors meet to get it right for new Orange hospital

The furore over the new Bathurst hospital which has been deemed dysfunctional by medical staff is now being followed by another uproar this time over plans for a new hospital in Orange in central western New South Wales.

21 Feb 2008

Different treatments for acute kidney failure often have similar outcomes

An analysis of studies examining treatments for acute kidney failure indicates that intermittent hemodialysis and continuous kidney replacement therapy appear to lead to similar clinical outcomes, including a similar risk of death, according to an article in the February 20 issue of JAMA: The Journal of the American Medical Association.

20 Feb 2008

Warning about deaths and serious reactions linked to blood thinning drug heparin

The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.

13 Feb 2008

Baxter's multiple-dose vial Heparin linked to severe allergic reactions

The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug.

11 Feb 2008

Why is scratching so nice?

In the first study to use imaging technology to see what goes on in the brain when we scratch, researchers at Wake Forest University Baptist Medical Center have uncovered new clues about why scratching may be so relieving - and why it can be hard to stop. The work is reported online in the Journal of Investigative Dermatology and will appear in a future print issue.

31 Jan 2008

British Prime Minister in favour of presumed consent for organ transplants

British Prime Minister Gordan Brown is calling for a debate on organ donation and says he is in favour of a policy known as "presumed consent" ; this would allow for organs to be transplanted without consent.

14 Jan 2008

Drug deferoxamine boosts bone healing and re-growth

A drug originally used to treat iron poisoning can significantly boost the body's own ability to heal and re-grow injured bones, according to researchers at the University of Alabama at Birmingham (UAB).

10 Jan 2008

Americans pay the most for prescription drugs and still don't take them

An international study of dialysis patients shows that although U.S. residents have the highest out-of-pocket drug costs, even those who can afford their prescription drugs are far less likely to take them than patients in other countries.

9 Jan 2008

FDA clears first rapid blood test for MRSA

The U.S. Food and Drug Administration (FDA) has announced it has cleared for marketing the first rapid blood test for the drug-resistant staph bacterium known as MRSA (methicillin-resistant Staphylococcus aureus), which can cause potentially deadly infections.

3 Jan 2008

FDA approves Voluven for blood loss post surgery

The U.S. Food and Drug Administration has approved Voluven, an intravenous solution that prevents and treats a dangerous loss of blood volume, a condition that sometimes occurs during and after surgery.

28 Dec 2007